Dipeptidyl Peptidase-4 Inhibitors and COVID-19-Related Deaths among Patients with Type 2 Diabetes Mellitus: A Meta-Analysis of Observational Studies

The coronavirus disease 2019 (COVID-19) pandemic remains an unbeaten enemy. Unfortunately, no targeted treatment option is available. Patients with type 2 diabetes mellitus (T2DM) have increased odds for severe or fatal disease, as demonstrated in recent observational studies. There is an ongoing di...

Descripción completa

Detalles Bibliográficos
Autores principales: Patoulias, Dimitrios, Doumas, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Endocrine Society 2021
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419608/
https://www.ncbi.nlm.nih.gov/pubmed/34311543
http://dx.doi.org/10.3803/EnM.2021.1048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419608/
https://www.ncbi.nlm.nih.gov/pubmed/34311543
http://dx.doi.org/10.3803/EnM.2021.1048

Ejemplares similares